Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Indonesian Journal of Chemistry Jurnal Biomedika dan Kesehatan
Emad Yousif
Department of Chemistry, College of Science, Al-Nahrain University, Baghdad 64021, Iraq
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Synthesis and Characterization of Zn(II), Cu(II), and Ni(II)-Levofloxacin Complexes for Carbon Dioxide Storage Media Hadeel Adil; Hamsa Thamer; Dina Saadi Ahmed; Raghda Alsayed; Muna Bufaroosha; Khalid Zainulabdeen; Hassan Hashim; Alaa Mohammed; Emad Yousif
Indonesian Journal of Chemistry Vol 23, No 5 (2023)
Publisher : Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijc.84552

Abstract

Three complexes ([CuL2(H2O)2], [NiL2(H2O)2], and [ZnL2Cl2]) have been synthesized through the reaction of metal salts and levofloxacin and characterized by spectrophotometers. The morphology of the complexes was investigated using field emission scanning electron microscopy (FESEM). The physicochemical properties of these complexes were evaluated using the Brunauer-Emmett-Teller (BET) and Barrett-Joyner-Halenda (BJH) techniques. Furthermore, the storage capacity of these complexes was verified using the H-sorb 2600 analyzer at a temperature of 323 K and varying pressure conditions. The obtained data substantiates that the synthesized complexes exhibit favorable attributes for CO2 absorption. The surface area reaches 24.97 m2/g with capacities of 123.073 m3/g and 34.400 m3/g to adsorb CO2. The escalating levels of CO2 in the atmosphere, primarily resulting from the combustion of fossil fuels to meet the surging energy requirements, pose a pressing environmental challenge. Consequently, there has been a surge in research focused on the development of novel materials aimed at facilitating CO2 storage.
Resveratrol dalam Pengobatan Integratif: Menjembatani Pengetahuan Tradisional dan Terapi Modern Raghda Al-Sayed; Atheel Alwash; Khalid Zainulabdeen; Reem Waleed; Muna Bufaroosha; Shams Ismeal; Nany Hairunisa; Husnun Amalia; Hazim F Abbas; Emad Yousif
Jurnal Biomedika dan Kesehatan Vol 9 No 2 (2026)
Publisher : Fakultas Kedokteran Universitas Trisakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18051/JBiomedKes.2026.v9.240-253

Abstract

Resveratrol is a polyphenolic stilbenoid found in plants such as grapes, berries, and peanuts, widely recognized for its antioxidant, anti-inflammatory, anticancer, antidiabetic, cardioprotective, neuroprotective, and anti-aging properties. Despite extensive preclinical evidence, its clinical translation remains limited by poor bioavailability and inconsistent trial outcomes. This review aims to synthesize current evidence on resveratrol’s mechanisms of action, therapeutic effects across disease models, synergistic drug interactions, and translational challenges, with a focus on its integration into modern integrative medicine. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science using the terms “resveratrol,” “polyphenol,” “integrative medicine,” and disease-specific keywords. The resuls was Resveratrol demonstrated anticancer effects via apoptosis induction and cell cycle arrest, cardioprotective effects through AMPK/SIRT1/eNOS activation, neuroprotection via Akt/PI3K signaling, and antidiabetic effects through improved insulin sensitivity. Synergistic interactions were identified with metformin (diabetes), statins/aspirin (cardiovascular disease), and chemotherapeutic agents (cancer). Bioavailability and formulation remain major challenges. Conclusion of this study Resveratrol holds significant therapeutic promise in integrative medicine, though robust clinical trials are needed to confirm efficacy and establish safe dosing protocols for clinical application.
Co-Authors Alaa Mohammed Atheel Alwash Dina Saadi Ahmed Hadeel Adil Hairunisa, Nany Hamsa Thamer Hassan Hashim Hazim F Abbas Husnun Amalia Khalid Zainulabdeen Muna Bufaroosha Muna Bufaroosha Raghda Al-Sayed Raghda Alsayed Reem Waleed Shams Ismeal